And if people are experiencing weight loss before they reach the top dose, there is no need to increase it, said Professor Drucker
The injection should not be used with any other products that contain tirzepatide or any GLP-1 receptor agonist medicines like Ozempic.
Isolated case reports describe immune-related adverse events in tirzepatide users, including one case of autoimmune encephalitis and one case of immune thrombocytopenia
This dual GIP/GLP-1 receptor agonist, approved by the FDA for type 2 diabetes and chronic weight management, may cause dizziness through several mechanisms including dehydration from gastrointestinal side effects, medication interactions affecting blood pressure, hypoglycemia when combined with insulin or sulfonylureas, and orthostatic hypotension related to weight loss
If you notice any of these signs, it is best to discard the product to ensure you are using a supplement that is effective and safe
This effect can lead to reduced calorie intake and potentially significant weight loss over time